Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.075 | 0.7 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |